CHRS icon

Coherus Oncology, Inc. Common Stock
CHRS

Overview Fund Activity

115 hedge funds and large institutions have $867M invested in Coherus Oncology, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 25 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+12
Holders Change %
+11.65%
% of All Funds
2.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
48
Reduced
25
Closed
15
Calls
$14.6M
Puts
$9.23M
Net Calls
+$5.4M
Net Calls Change
+$4.38M

Top Buyers

1
FCM
Farallon Capital Management
California
$11.8M
2
BlackRock
BlackRock
New York
$58M
3
HP
Hound Partners
New York
$10.9M
4
Deutsche Bank
Deutsche Bank
Germany
$18.4M
5
MWNA
Marshall Wace North America
New York
$8.96M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$96.5M
2
HCM
Highbridge Capital Management
New York
$0
3
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
$1.08M
4
SFM
Sphera Funds Management
Israel
$0
5
Ameriprise
Ameriprise
Minnesota
$3.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
Parallax Volatility Advisers
126
Parallax Volatility Advisers
California
– -$94K -8,514 Closed
FPFS
127
First Personal Financial Services
North Carolina
– -$10K -876 Closed
APA
128
American Portfolios Advisors
New York
– -$1.34K -121 Closed
2 3 4 5
6